What's new

EMEA-003215-PIP01-22-M01

EMEA-003215-PIP01-22-M01

Jun 5, 2025 - 16:20
 0
EMEA-003215-PIP01-22-M01
EMEA-003215-PIP01-22-M01
Read More

Tags:

Previous Article

EMEA-003220-PIP01-22-M01

Next Article

PSUSA/00000795/202410

Related Posts

Human medicines European public assessment report (EPAR): Isentress, raltegravir, Date of authorisation: 19/12/2007, Revision: 44, Status: Authorised

Human medicines European public assessment report (EPAR...

May 14, 2025  0

Summary of opinion: Imfinzi, 22/05/2025 Positive

Summary of opinion: Imfinzi, 22/05/2025 Positive

May 23, 2025  0

Nitrosamine impurities: guidance for marketing authorisation holders

Nitrosamine impurities: guidance for marketing authoris...

May 28, 2025  0